1. Home
  2. IMAB vs RFM Comparison

IMAB vs RFM Comparison

Compare IMAB & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • RFM
  • Stock Information
  • Founded
  • IMAB 2014
  • RFM 2020
  • Country
  • IMAB United States
  • RFM United States
  • Employees
  • IMAB 220
  • RFM N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • RFM Finance/Investors Services
  • Sector
  • IMAB Health Care
  • RFM Finance
  • Exchange
  • IMAB Nasdaq
  • RFM Nasdaq
  • Market Cap
  • IMAB 79.9M
  • RFM 92.3M
  • IPO Year
  • IMAB 2020
  • RFM N/A
  • Fundamental
  • Price
  • IMAB $0.97
  • RFM $15.70
  • Analyst Decision
  • IMAB Strong Buy
  • RFM
  • Analyst Count
  • IMAB 3
  • RFM 0
  • Target Price
  • IMAB $8.00
  • RFM N/A
  • AVG Volume (30 Days)
  • IMAB 274.1K
  • RFM 20.7K
  • Earning Date
  • IMAB 03-13-2025
  • RFM 01-01-0001
  • Dividend Yield
  • IMAB N/A
  • RFM 9.74%
  • EPS Growth
  • IMAB N/A
  • RFM N/A
  • EPS
  • IMAB N/A
  • RFM N/A
  • Revenue
  • IMAB $3,313,984.00
  • RFM N/A
  • Revenue This Year
  • IMAB N/A
  • RFM N/A
  • Revenue Next Year
  • IMAB N/A
  • RFM N/A
  • P/E Ratio
  • IMAB N/A
  • RFM N/A
  • Revenue Growth
  • IMAB N/A
  • RFM N/A
  • 52 Week Low
  • IMAB $0.84
  • RFM $12.89
  • 52 Week High
  • IMAB $2.08
  • RFM $16.41
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 43.19
  • RFM 65.66
  • Support Level
  • IMAB $1.03
  • RFM $15.24
  • Resistance Level
  • IMAB $1.10
  • RFM $15.60
  • Average True Range (ATR)
  • IMAB 0.06
  • RFM 0.07
  • MACD
  • IMAB -0.01
  • RFM 0.05
  • Stochastic Oscillator
  • IMAB 7.58
  • RFM 99.98

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About RFM RiverNorth Flexible Municipal Income Fund Inc.

RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.

Share on Social Networks: